COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction.
Ontology highlight
ABSTRACT: Vascular injury has emerged as a complication contributing to morbidity in coronavirus disease 2019 (COVID-19). The glycosaminoglycan hyaluronan (HA) is a major component of the glycocalyx, a protective layer of glycoconjugates that lines the vascular lumen and regulates key endothelial cell functions. During critical illness, as in the case of sepsis, enzymes degrade the glycocalyx, releasing fragments with pathologic activities into circulation and thereby exacerbating disease. Here, we analyzed levels of circulating glycosaminoglycans in 46 patients with COVID-19 ranging from moderate to severe clinical severity and measured activities of corresponding degradative enzymes. This report provides evidence that the glycocalyx becomes significantly damaged in patients with COVID-19 and corre
SUBMITTER: Queisser KA
PROVIDER: S-EPMC8492325 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA